Glyburide (DiaBeta, Glynase, PresTab, Glycron, Micronase)

Unlike some anti-diabetic drugs which have been on the market for only a few years, glyburide has been approved for use by the Food and Drug Administration since 1984. Many diabetes patients find glyburide to be a safe and convenient way to maintain their blood glucose within their target range.

Glyburide overview

Brand names: Glyburide is marketed under the following brand names:

  • DiaBeta
  • Glynase PresTab
  • Glycron
  • Micronase

Drug class: Glyburide belongs to the sulfonylurea class of drugs. Other drugs in this class include glimepiride (Amaryl) and glipizide (Glucotrol). These drugs stimulate insulin production by the pancreas and can lower blood sugar levels by helping the body use insulin more effectively.

Dosage: Glyburide comes in an oral tablet, generally taken once each morning.

Side effects: The federal Agency on Healthcare Research and Quality reports glyburide can cause stomach problems such as heartburn and nausea, as well as weight gain. It is also associated with a three-to five-fold increase in the risk of unsafe low blood sugar levels.

Sign up for our newsletter
  • Get diabetes supplies
    delivered to your door.
  • Find companies that offer free
    delivery of the brands you want.

  • Diabetes supplies
     CPAP mask and tubing
  • How would you describe yourself?

  • Do you have Medicare as your primary insurance?
  • Yes No

Related Medications Content

Add a comment
Google Plus
(required) *
(required,will not be displayed) *
Can't read this?
Get two new words
Listen to the words